New Ray Medicine Restructures Leadership Amid Executive Resignation
Company Announcements

New Ray Medicine Restructures Leadership Amid Executive Resignation

New Ray Medicine International Holding Ltd. (HK:6108) has released an update.

New Ray Medicine International Holding Ltd. announced the resignation of Mr. Huo Zhihong as an executive director and member of its corporate governance committee, effective October 16, 2024, due to his other business commitments. The company has restructured its corporate governance committee with Ms. Wang Qiuqin as the new chairman. The board expressed gratitude for Mr. Huo’s contributions during his tenure.

For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App